We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

106 hedge funds and large institutions have $308M invested in Voyager Therapeutics in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 16

71% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 21

68% more capital invested

Capital invested by funds: $184M → $308M (+$124M)

40% more call options, than puts

Call options by funds: $1.27M | Put options by funds: $913K

31% more funds holding

Funds holding: 81 → 106 (+25)

6.72% more ownership

Funds ownership: 55.01% → 61.73% (+6.7%)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
106
Holders Change
+25
Holders Change %
+30.86%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
36
Reduced
21
Closed
16
Calls
$1.27M
Puts
$913K
Net Calls
+$361K
Net Calls Change
+$1.05M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5.29M
3
Morgan Stanley
Morgan Stanley
New York
+$5.21M
4
FCM
Farallon Capital Management
California
+$5.12M
5
State Street
State Street
Massachusetts
+$4.66M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$24.6M
2
Millennium Management
Millennium Management
New York
-$11.9M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.64M
4
Jane Street
Jane Street
New York
-$1.32M
5
Goldman Sachs
Goldman Sachs
New York
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
51
Corton Capital
Ontario, Canada
$462K +$417K +40,306 New
VI
52
Vestcor Inc
New Brunswick, Canada
$437K +$394K +38,128 New
CCIA
53
Campbell & Co Investment Adviser
Maryland
$424K +$66.5K +6,431 +21%
SOW
54
State of Wyoming
Wyoming
$390K +$352K +34,073 New
SEI Investments
55
SEI Investments
Pennsylvania
$387K +$350K +33,788 New
FAM
56
Fred Alger Management
New York
$365K +$329K +31,848 New
RJFSA
57
Raymond James Financial Services Advisors
Florida
$356K -$1.81K -175 -0.6%
Franklin Resources
58
Franklin Resources
California
$350K +$132K +12,772 +72%
Two Sigma Advisers
59
Two Sigma Advisers
New York
$349K -$47.6K -4,600 -13%
SO
60
STRS Ohio
Ohio
$335K +$303K +29,300 New
VF
61
Virtu Financial
New York
$319K +$288K +27,855 New
Bank of America
62
Bank of America
North Carolina
$315K -$208K -20,127 -42%
UBS Group
63
UBS Group
Switzerland
$296K +$215K +20,785 +411%
SSA
64
Schonfeld Strategic Advisors
New York
$284K +$257K +24,800 New
WG
65
Winton Group
United Kingdom
$279K +$252K +24,342 New
ECM
66
ExodusPoint Capital Management
New York
$278K +$252K +24,321 New
EGM
67
Engineers Gate Manager
New York
$261K +$236K +22,830 New
OSAM
68
O'Shaughnessy Asset Management
Connecticut
$256K +$231K +22,359 New
Lazard Asset Management
69
Lazard Asset Management
New York
$253K +$106K +10,260 +86%
CANY
70
Caxton Associates (New York)
New York
$252K -$151K -14,559 -40%
CAPTRUST Financial Advisors
71
CAPTRUST Financial Advisors
North Carolina
$252K +$228K +22,000 New
DU
72
Delphia (USA)
Ontario, Canada
$238K +$215K +20,781 New
AllianceBernstein
73
AllianceBernstein
Tennessee
$220K +$199K +19,240 New
CSS
74
Cubist Systematic Strategies
Connecticut
$210K -$800K -77,324 -81%
MIM
75
MetLife Investment Management
New Jersey
$193K +$174K +16,821 New
1 2
3
4 5

VYGR Hedge Fund Activity: Q2 2023 in Review

106 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q2 2023, worth a combined $308M — up 68% from $184M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new VYGR positions and 16 closed out — a net gain of 25 holders — while 36 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $17.1M. The largest seller was TRV GP III, exiting entirely with an estimated $24.6M sold.

  • 106 institutional investors held Voyager Therapeutics (VYGR) as of Q2 2023, up from 81 in Q1 2023.
  • Funds reported $308M of Voyager Therapeutics stock for Q2 2023, up 68% quarter-over-quarter.
  • 41 funds opened new Voyager Therapeutics positions in Q2 2023 and 16 closed out, a net change of +25 holders.
  • The largest Voyager Therapeutics buyer in Q2 2023 was BlackRock, an estimated $17.1M added.
  • The largest Voyager Therapeutics seller in Q2 2023 was TRV GP III, an estimated $24.6M sold.

Based on aggregated 13F filings for Q2 2023.